Covid-19 - global mix / investigation of covid-19 disease parameters for transmission models in low-resource settings

Active Project Grant Awarded Last action

Award ID
R01AI161399
Recipient
Awarding agency
Obligated
$8,830,744

Award facts

Assistance listing
93.855 Allergy and Infectious Diseases Research
Completion date 93% complete
Place of performance
Dallas, TX 75390, USA

Award details come from USAspending.gov.

Description

Abstract
We began to quantify household- and community-level interactions in 2019 with our project, "comprehensive profiling of social mixing patterns in resource poor countries" ("globalmix", grant R01 HD097175-01) to investigate human-to-human interactions relevant for respiratory infection transmission. This proposal will build on existing globalmix study infrastructure to estimate lmic-specific epidemiologic parameters for covid-19. In the proposed study, we will connect field epidemiology and mathematical modeling approaches by estimating the rate of, and heterogeneity in, household-based transmission of sars- COV-2 through longitudinal cohort approaches. We will use this information in conjunction with highly-granular data on social interactions from globalmix to identify key epidemiological parameters for covid-19, including the community-level force of infection and attack rates within households. We will then use this information to build lmic-specific dynamic models, to evaluate the impact of key interventions to reduce transmission: vaccination and non-pharmaceutical interventions such as face masks, shelter-in-place policies and school closure. This work will be completed in three specific aims: aim 1: quantify covid-19 transmission across contact networks within the household environment. We will conduct longitudinal respiratory disease surveillance in households participating in the globalmix study. We will collect longitudinal samples of respiratory specimens from household members for identification of covid-19 and other respiratory pathogens such as influenza. This information will be overlaid on contact network data from globalmix. Aim 2: estimate key epidemiological features of sars-COV-2 and other respiratory pathogens in lmic settings. We will collect blood specimens from globalmix study participants and test for antibody levels (IGG) against sars-COV-2. We will calculate age-specific infection fatality rates (ifrs) and use antibody titers to infer time of infection and calculate community-level incidence over time. We will generate age-structured seroprevalence curves, which will provide a robust measure of exposure across the age range. Together with the contact data from globalmix, we will infer age-specific transmission probabilities that will be used as inputs into the network models in aim 3. Samples will be stored for future testing, including antibody avidity and t/b cell activation. Aim 3. Estimate the impact of control measures on covid-19 in lmic. We will use the epidemiological parameters estimated in aim 1 and the setting- and age-specific force of infection estimates from aim 2 to parameterize dynamic network-based mathematical models of disease transmission. Models will incorporate social mixing data from globalmix to project the impact of extended shelter-in-place policies, policies concerning the use of face masks, and the introduction of a sars-COV-2 vaccine.

Transactions

Action Obligated Date
Amendment $82,554
Amendment $6,912
Amendment $3,454
Amendment $566,629
Amendment $48,219
Amendment $5,259
Amendment $168,350
Amendment $48,219
Amendment $5,259
Amendment $168,350
Amendment $400,628
Amendment $400,628
Amendment $0
Amendment $64,101
Amendment $64,101
Amendment $576,903
Amendment $576,903
Amendment $576,903
Amendment $464,178
Amendment -$194,051
Amendment -$270,127
Amendment $464,178
Amendment -$194,051
Amendment -$270,127
Amendment $464,178
Amendment -$194,051
Amendment -$270,127
Amendment $429,037
Amendment $429,037
Amendment $429,037
Amendment $429,037
Amendment -$429,037
Amendment -$429,037
Amendment -$429,037
Amendment Covid global mix - global mix / investigation of covid-19 disease parameters for transmission models in low-resource settings -$429,037
Amendment $699,164
Amendment $699,164
Amendment $699,164
Amendment $699,164
Amendment Covid global mix - global mix / investigation of covid-19 disease parameters for transmission models in low-resource settings $699,164
Amendment $785,776
Original award $785,776
Show all 42

Subawards

Subrecipient Amount Awarded
Emory University Dr. Lopman will provide oversight and leadership in collaboration with the Dr. Omen on all of the scientific aims. Drs. Lopman and Nelson and the team at… $688,405
Fundacao Manhica I. Scope: Dr. Massora will be responsible for the overall coordination of study activities at the CISM/Manhica site. Dr. Massora will contribute to protocol and… $315,603
Yale Univ Dr. Warren will oversee power and sample size calculations, as well as statistical modeling of the collected data. He will also develop methods as needed.… $657,853
The Christian Medical College Vellore Association Coordinate development of assays and testing biological samples at CMC in Vellore. The CMC shall independently perform all work and furnish all labor,… $175,262

Quick answers

Who received award R01AI161399?

R01AI161399 was awarded to The University Of Texas Southwestern Medical Center by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on March 1, 2022.

How much is award R01AI161399 worth?

$8,830,744 has been obligated on R01AI161399.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award